BLTE Belite Bio
- 69.710
- -0.190-0.27%
Belite Bio News
Belite Bio | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Belite Bio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Belite Bio | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Belite Bio | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Belite Bio | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Belite Bio | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Belite Bio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Belite Bio | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Belite Bio | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Belite Bio | F-3: Registration statement for specified transactions by certain foreign private issuers
Belite Bio | F-3: Registration statement for specified transactions by certain foreign private issuers
Belite Bio | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Belite Bio | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Belite Bio | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Belite Bio | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Belite Bio | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Belite Bio | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Belite Bio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Belite Bio | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Belite Bio | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Analysis
Price Target
No Data
No Data